Abstract:The prognosis of patients with HCC still remains dismal. The life expectancy of HCC patients is hard to predict because of the high possibility of postoperative recurrence. Many factors, such as patient's general conditions, macroscopic tumor morphology, as well as tumor histopathology features, have been proven of prognostic significance. Female HCC patient often has a better prognosis than male patient, which might be due to the receptor of sex hormones. Younger patients often have tumors with higher invasiveness and metastatic potentials, and their survival and prognosis are worse than the older ones. Co-existing hepatitis status and hepatic functional reserve have been confirmed as risk factors for recurrence. Serum alpha-fetoprotein (AFP) is useful not only for diagnosis, but also as a prognostic indicator for HCC patients. AFP mRNA has been proposed as a predictive marker of HCC cells disseminated into the circulation and for metastatic recurrence. Many pathologic features, such as tumor size, number, capsule state, cell differentiation, venous invasion, intrahepatic spreading, and advanced pTNM stage, are the best-established risk factors for recurrence and important aspects affecting the prognosis of patients with HCC. Marked inflammatory cell infiltration in the tumor could predict a better prognosis. Clinical stage is still the most important factor influencing on the prognosis. Extratumor spreading and lymph nodal metastasis are independent predictors for poor outcome. Some new predictive systems have recently been proposed. Different strategies of treatment might have significant different effects on the patients' prognosis. To date, surgical resection is still the only potentially curative treatment for HCC, including localized postoperative recurrences. Extent of resection, blood transfusion, occlusion of porta hepatis, and blood loss affect the survival and prognosis of HCC patients. Regional therapies provide alternative ways to improve the prognosis of HCC patients who have no opportunity to receive surgical treatment or postoperative recurrence. The combination of these treatment modalities is hopeful to further improve the prognosis. The efficacies of neoadjuvant (preoperative) or adjuvant (postoperative) chemotherapy or chemoembolization in preventing recurrence and on the HCC prognosis still remain great controversy, and deserve further evaluation. Biotherapy, including IFN-alpha therapy, will play more important role in preventing recurrence and metastasis of HCC after operation.

Erratum to Bcl-2 Expression is a Poor Predictor for Hepatocellular Carcinoma Prognosis of Andropause-Age Patients

BC047440 Overexpression is a Risk Factor for Tumor Invasion and Poor Prognosis in Hepatocellular Carcinoma.

Prognostic Significance of Preoperative Serum Alpha- Fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

Clinicopathological Features, Postoperative Survival and Prognostic Influencing Factors of Male Patients with Hepatocellular Carcinoma

[Expression and Prognostic Value of BCL-2 Protein in Diffuse Large B-cell Lymphoma].

Prognostic analysis of sex and age in hepatocellular carcinoma: a SEER study

Prognostic Value of Bcl-2 Expression in Patients with Non-Small-cell Lung Cancer: a Meta-Analysis and Systemic Review.

Age-dependent Female Survival Advantage in Hepatocellular Carcinoma: A Multicenter Cohort Study

Expression of Bcl-2,C-myc protein in hepatocellular carcinoma and its relation to prognosis

Gender difference in endoplasmic reticulum stress and apoptosis signals in patients with hepatocellular carcinoma

The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

The Influence of High Serum Testosterone Levels on the Long-term Prognosis in Male Patients Undergoing Hepatectomy for Early Stage Hepatocellular Carcinoma without Vascular Invasion

High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis

Comparative Analysis of Molecular Aberration in Different Genders for Identification of Key Pathways in Hepatocellular Carcinoma.

Correlation and Prognostic Value of Osteopontin and Bcl-2 in Hepatocellular Carcinoma Patients after Curative Resection

Distinguished Prognosis of Hepatocellular Carcinoma with or Without Cirrhosis: A Long-term Follow-up Analysis

Prognostic and Subgroup Analysis of 162 Patients with Barcelona Clinical Liver Cancer (BCLC) Stage B Hepatocellular Carcinoma after Hepatectomy

Sex Differences in Genomic Features of Hepatitis B-Associated Hepatocellular Carcinoma With Distinct Antitumor Immunity

Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection.

Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma

Clinical Characteristics, Outcome, and Risk Factors for Early and Late Intrahepatic Recurrence of Female Patients after Curative Resection of Hepatocellular Carcinoma.